C. Oliveira

From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.

N. Desroy, F. Moreau, V. Gerusz, 2012, Journal of medicinal chemistry.

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1.

P. Soulard, P. Berna, B. Bertin, 2004, Bioorganic & medicinal chemistry letters.

Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.

N. Desroy, F. Moreau, V. Gerusz, 2008, Bioorganic & medicinal chemistry letters.

Novel HldE-K inhibitors leading to attenuated Gram negative bacterial virulence.

M. Junop, N. Desroy, F. Moreau, 2013, Journal of medicinal chemistry.

Structural–Functional Studies of Burkholderia cenocepaciad-Glycero-β-d-manno-heptose 7-Phosphate Kinase (HldA) and Characterization of Inhibitors with Antibiotic Adjuvant and Antivirulence Properties

M. Valvano, M. Junop, Christian Stanetty, 2012, Journal of medicinal chemistry.

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies.

P. Soulard, P. Berna, B. Bertin, 2004, Bioorganic & medicinal chemistry letters.

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: metabolism-directed optimization studies towards orally bioavailable derivatives.

P. Berna, R. Wrigglesworth, P. Ducrot, 2004, Bioorganic & medicinal chemistry letters.

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 2: Optimization of 5,8-disubstituted derivatives.

P. Berna, B. Bertin, P. Ducrot, 2004, Bioorganic & medicinal chemistry letters.